// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "EXPRESS individual COLUMN CN LIMITED data file MINOR BE HCD NCE NOTE ISA EFO ALL CL CID pooled sample fractionation method RECOMMEND MAY CPTAC SP sample instrument IMPORTANT TO MAGE THE ZFA PO TMT HANCESTRO reduction reagent technical replicate MT SILAC III SRM dissociation method source name_ and _assay name organism REQUIRED age RECOMMENDED CS OPTIONAL spiked compound NOT HTML PP IAA INITIATIVE WILL disease IDF ROW OF PURPOSE proteomics data acquisition method INCLUDING PRIDE:0000659 XL SHOULD AC MAJOR FDR SDRF TAB PATCH PEPTIDESEQ RFC CV DOID AS RAW BUT JA LI CF WARRANTY PRIDE INFRINGE RIGHTS HF exclamation DTT DIA OR EW alkylation reagent ANY EM MC cell type biosample accession number II depletion PROTEOMICS DJ BRENDA HUPO MERCHANTABILITY SN mass LC PATO QY TA PRM organism part MOD IS INFORMATION TIP SHALL URI FITNESS STANDARDS BMC MIAME WARRANTIES SH VCF URL NT cleavage agent details fraction identifier REQUIRES PS THAT VK disease stage MUST XML replicate MS:1001251 ID BTO DDA USE README PMID label MONDO NCBI MANDATORY PARTICULAR CELL MS SWATH CLO IMPLIED ancestry category collision energy PSI characteristics ENVO file your sex PTM COULD HEREIN EBI ... source name DISCLAIMS FOR PMCID developmental stage MHC biological replicate UBERON CT"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "EXPRESS individual COLUMN CN LIMITED data file MINOR BE HCD NCE ISA EFO ALL CL CID pooled sample fractionation method RECOMMEND MAY CPTAC SP instrument TO MAGE THE ZFA PO TMT HANCESTRO reduction reagent technical replicate MT SILAC III SRM dissociation method organism REQUIRED age RECOMMENDED CS OPTIONAL spiked compound NOT HTML PP IAA INITIATIVE WILL disease IDF ROW OF PURPOSE proteomics data acquisition method INCLUDING PRIDE:0000659 XL SHOULD AC MAJOR FDR SDRF TAB PATCH PEPTIDESEQ RFC CV DOID AS RAW BUT JA LI CF WARRANTY PRIDE INFRINGE RIGHTS HF DTT DIA OR EW alkylation reagent ANY EM MC cell type biosample accession number II depletion PROTEOMICS DJ BRENDA HUPO MERCHANTABILITY SN mass LC PATO QY TA PRM organism part MOD IS INFORMATION SHALL URI FITNESS STANDARDS BMC MIAME WARRANTIES SH VCF URL NT cleavage agent details fraction identifier REQUIRES PS THAT VK disease stage MUST MS:1001251 BTO DDA USE README PMID label MONDO NCBI MANDATORY PARTICULAR CELL MS SWATH CLO IMPLIED ancestry category collision energy PSI ENVO sex PTM COULD HEREIN EBI ... DISCLAIMS FOR PMCID MHC biological replicate UBERON CT"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "CL:0000788 CL:0000451 CL:0000182 individual UBERON:0002097 disease model NOTE EFO ALL CL COVID MAY PATO:0001340 IMPORTANT UBERON:0001155 MONDO:0005148 PO CL:0000084 HANCESTRO MONDO:0005105 CL:0000540 UBERON:0002113 enrichment process MONDO:0005180 UBERON:0001977 CL:0000057 organism CL:0000236 age CL:0000235 disease UBERON:0001359 CL:0000815 MONDO:0005138 synthetic peptide MONDO:0100096 SHOULD SDRF DOID UBERON:0001969 CL:0000625 exclamation UBERON:0002048 PATO:0000461 UBERON:0002107 compound MONDO:0005575 CL:0000066 cell type MONDO:0004989 CL:0000787 depletion PATO PATO:0000383 xenograft MONDO:0004946 organism part UBERON:0000948 MONDO:0004975 TIP NSG MONDO:0005301 CL:0000623 UBERON:0000955 APP URL UBERON:0000178 CL:0000913 MUST ID PDX lib MONDO NCBI UBERON:0000310 PATO:0000384 CL:0000813 CL:0000232 CSF ancestry category CL:0000624 sex PTM NK UBERON:0001088 CL:0000898 CL:0000576 source name CL:0000233 MONDO:0008383 developmental stage biological replicate UBERON CML DSS"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "CL:0000788 CL:0000451 CL:0000182 individual UBERON:0002097 disease model EFO ALL CL COVID MAY PATO:0001340 UBERON:0001155 MONDO:0005148 PO CL:0000084 HANCESTRO MONDO:0005105 CL:0000540 UBERON:0002113 enrichment process MONDO:0005180 UBERON:0001977 CL:0000057 organism CL:0000236 age CL:0000235 disease UBERON:0001359 CL:0000815 MONDO:0005138 synthetic peptide MONDO:0100096 SHOULD SDRF DOID UBERON:0001969 CL:0000625 UBERON:0002048 PATO:0000461 UBERON:0002107 compound MONDO:0005575 CL:0000066 cell type MONDO:0004989 CL:0000787 depletion PATO PATO:0000383 xenograft MONDO:0004946 organism part UBERON:0000948 MONDO:0004975 NSG MONDO:0005301 CL:0000623 UBERON:0000955 APP URL UBERON:0000178 CL:0000913 MUST ID PDX MONDO NCBI UBERON:0000310 PATO:0000384 CL:0000813 CL:0000232 CSF ancestry category CL:0000624 sex PTM NK UBERON:0001088 CL:0000898 CL:0000576 source name CL:0000233 MONDO:0008383 developmental stage biological replicate UBERON CML DSS"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "individual NCIT:C65107 NCIT:C68804 NOTE EFO NCIT:C15445 tumor grade MONDO:0011122 IMPORTANT PREFERRED ethnicity MONDO:0005148 MONDO:0004979 CHEBI:41774 HANCESTRO MONDO:0004995 NCIT:C14167 NCI III NCIT:C18206 AJCC GDPR NCIT:C53556 organism NCIT:C71732 age gestational age TNM staging CHEBI:28748 breast cancer subtype disease treatment NCIT:C53555 NCIT:C15632 dose NCIT:C14168 ACE CHEBI:6801 SDRF ER HANCESTRO:0006 PR NCIT:C53554 NCIT:C81327 sampling time point Ann Arbor stage HANCESTRO:0005 exclamation MONDO:0005044 alcohol consumption compound NCIT:C28054 weight CHEBI:27899 treatment response NCIT HANCESTRO:0010 II NCIT:C62723 NCIT:C27970 NCIT:C28079 diet NCIT:C16358 pre-existing condition TNM height NCIT:C28076 BMI NCIT:C27971 PD treatment status organism part menopausal status Dukes stage MONDO:0005300 NCIT:C14174 NCIT:C14169 NCIT:C18058 medication history NCIT:C18213 disease stage NCIT:C27966 NCIT:C15262 ID body mass index MONDO NCIT:C15313 NCIT:C4870 MONDO:0002050 secondary condition NCIT:C65106 HANCESTRO:0009 ancestry category NCIT:C15329 time post treatment NCIT:C28077 NCIT:C65108 sex prior treatment NCIT:C28078 NCIT:C53553 UO smoking status NCIT:C81328 pregnancy status IV HIPAA"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "individual NCIT:C65107 NCIT:C68804 EFO NCIT:C15445 tumor grade MONDO:0011122 PREFERRED ethnicity MONDO:0005148 MONDO:0004979 CHEBI:41774 HANCESTRO MONDO:0004995 NCIT:C14167 NCI III NCIT:C18206 AJCC GDPR NCIT:C53556 organism NCIT:C71732 age gestational age TNM staging CHEBI:28748 breast cancer subtype disease treatment NCIT:C53555 NCIT:C15632 dose NCIT:C14168 ACE CHEBI:6801 SDRF ER HANCESTRO:0006 PR NCIT:C53554 NCIT:C81327 sampling time point Ann Arbor stage HANCESTRO:0005 MONDO:0005044 alcohol consumption compound NCIT:C28054 weight CHEBI:27899 treatment response NCIT HANCESTRO:0010 II NCIT:C62723 NCIT:C27970 NCIT:C28079 diet NCIT:C16358 pre-existing condition TNM height NCIT:C28076 BMI NCIT:C27971 PD treatment status organism part menopausal status Dukes stage MONDO:0005300 NCIT:C14174 NCIT:C14169 NCIT:C18058 medication history NCIT:C18213 disease stage NCIT:C27966 NCIT:C15262 ID body mass index MONDO NCIT:C15313 NCIT:C4870 MONDO:0002050 secondary condition NCIT:C65106 HANCESTRO:0009 ancestry category NCIT:C15329 time post treatment NCIT:C28077 NCIT:C65108 sex prior treatment NCIT:C28078 NCIT:C53553 UO smoking status NCIT:C81328 pregnancy status IV HIPAA"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "REQUIRED MS:1001303 RECOMMENDED CS MUST UNIMOD MGF PP data file MSD TOF MS:1001251 MS:1001306 ID KR NOTE ELISA DDA label scan window lower limit proteomexchange accession number TA UNIMOD:21 proteomics data acquisition method precursor mass tolerance sample instrument PRM XL SHOULD IMPORTANT MS AC MOD UNIMOD:737 MS1 scan range TIP SDRF FTP MS:1001917 MS:1001309 URI PSI MM ST UNIMOD:4 UNIMOD:1 modification parameters TMT SCIEX UNIMOD:35 RAW technical replicate MT scan window upper limit CF file uri PRIDE HF exclamation SILAC RPPA fragment mass tolerance SRM TS URL DIA MS:1001313 NT fraction identifier MS2 analyzer type cleavage agent details MRM LTQ PRIDE:0000663 fraction"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "REQUIRED MS:1001303 RECOMMENDED CS MUST UNIMOD MGF PP data file MSD TOF MS:1001251 MS:1001306 ID KR ELISA DDA label scan window lower limit proteomexchange accession number TA UNIMOD:21 proteomics data acquisition method precursor mass tolerance instrument PRM XL SHOULD MS AC UNIMOD:737 MOD MS1 scan range FTP SDRF MS:1001917 MS:1001309 URI PSI MM ST UNIMOD:4 UNIMOD:1 modification parameters TMT SCIEX UNIMOD:35 RAW technical replicate MT scan window upper limit CF file uri PRIDE HF SILAC RPPA fragment mass tolerance SRM TS URL DIA MS:1001313 NT fraction identifier MS2 analyzer type cleavage agent details MRM LTQ PRIDE:0000663"
  }
];
